CEL-SCI completes $10 million stock offering for drug development
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| CEL-SCI CORPORATION (NYSE: CVM) | Delayed: 1.74 +0.03 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $0.66 | |||
| Open | $1.69 | 52 Week Low | $0.20 | |||
| Day High | $1.78 | P/E | N/A | |||
| Day Low | $1.66 | EPS | $-0.34 | |||
| Volume | 72,257 | |||||
